# Genesco Inc: overview

GCO · NYSE · CIK 18498 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Jan 30

Pages: [Overview](/companies/gco.md) · [Financials](/companies/gco/financials.md) · [Filings](/companies/gco/filings.md) · [Insiders](/companies/gco/insiders.md)

Latest reported revenue: [$529.9m](/filings/0001193125-26-387556.md) for Q2 FY2027, three months to 2026-08-01, from the 10-Q filed Sep 10, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001193125-26-387556).

## Last eight quarters

| Line item | Unit | Q3 FY2025 (2024-11-02) | Q4 FY2025 (2025-02-01) | Q1 FY2026 (2025-05-03) | Q2 FY2026 (2025-08-02) | Q3 FY2026 (2025-11-01) | Q4 FY2026 (2026-01-31) | Q1 FY2027 (2026-05-02) | Q2 FY2027 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [596](/filings/0001193125-25-315336.md) | [746 d](/filings/0001193125-26-123492.md) | [474](/filings/0001193125-26-266889.md) | [546](/filings/0001193125-26-387556.md) | [616](/filings/0001193125-25-315336.md) | [800 d](/filings/0001193125-26-123492.md) | [487](/filings/0001193125-26-266889.md) | [530](/filings/0001193125-26-387556.md) |
| Gross margin | % | [47.8%](/filings/0001193125-25-315336.md) | [46.9% d](/filings/0001193125-26-123492.md) | [46.7%](/filings/0001193125-26-266889.md) | [45.8%](/filings/0001193125-26-387556.md) | [46.8%](/filings/0001193125-25-315336.md) | [45.9% d](/filings/0001193125-26-123492.md) | [47.0%](/filings/0001193125-26-266889.md) | [51.4%](/filings/0001193125-26-387556.md) |
| Operating margin | % | [1.7%](/filings/0001193125-25-315336.md) | [6.2% d](/filings/0001193125-26-123492.md) | [(5.9%)](/filings/0001193125-26-266889.md) | [(2.6%)](/filings/0001193125-26-387556.md) | [1.4%](/filings/0001193125-25-315336.md) | [6.4% d](/filings/0001193125-26-123492.md) | [(3.2%)](/filings/0001193125-26-266889.md) | [0.7%](/filings/0001193125-26-387556.md) |
| Net margin | % | [(3.2%)](/filings/0001193125-25-315336.md) | [4.6% d](/filings/0001193125-26-123492.md) | [(4.5%)](/filings/0001193125-26-387556.md) | [(3.4%)](/filings/0001193125-26-387556.md) | [0.9%](/filings/0001193125-25-315336.md) | [6.0% d](/filings/0001193125-26-123492.md) | [(3.0%)](/filings/0001193125-26-387556.md) | [0.7%](/filings/0001193125-26-387556.md) |
| Diluted EPS | $ per share | [(1.76)](/filings/0001193125-25-315336.md) | not reported | [(2.02)](/filings/0001193125-26-266889.md) | [(1.79)](/filings/0001193125-26-387556.md) | [0.50](/filings/0001193125-25-315336.md) | not reported | [(1.42)](/filings/0001193125-26-266889.md) | [0.32](/filings/0001193125-26-387556.md) |
| Free cash flow | $m | [(36.2) d](/filings/0001193125-25-315336.md) | [103 d](/filings/0001193125-26-123492.md) | [(120)](/filings/0001193125-26-266889.md) | [71.7 d](/filings/0001193125-26-387556.md) | [(31.5) d](/filings/0001193125-25-315336.md) | [163 d](/filings/0001193125-26-123492.md) | [(118)](/filings/0001193125-26-266889.md) | [60.0 d](/filings/0001193125-26-387556.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2022 (2022-01-29) | FY2023 (2023-01-28) | FY2024 (2024-02-03) | FY2025 (2025-02-01) | FY2026 (2026-01-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,422](/filings/0000950170-24-036902.md) | [2,385](/filings/0000950170-25-044864.md) | [2,325](/filings/0001193125-26-123492.md) | [2,325](/filings/0001193125-26-123492.md) | [2,436](/filings/0001193125-26-123492.md) |
| Gross margin | % | [48.8%](/filings/0000950170-24-036902.md) | [47.6%](/filings/0000950170-25-044864.md) | [47.3%](/filings/0001193125-26-123492.md) | [47.2%](/filings/0001193125-26-123492.md) | [46.3%](/filings/0001193125-26-123492.md) |
| Operating margin | % | [6.4%](/filings/0000950170-24-036902.md) | [3.9%](/filings/0000950170-25-044864.md) | [(0.6%)](/filings/0001193125-26-123492.md) | [0.6%](/filings/0001193125-26-123492.md) | [0.7%](/filings/0001193125-26-123492.md) |
| Net margin | % | [4.7%](/filings/0000950170-24-036902.md) | [3.0%](/filings/0000950170-25-044864.md) | [(0.7%)](/filings/0001193125-26-123492.md) | [(0.8%)](/filings/0001193125-26-123492.md) | [0.5%](/filings/0001193125-26-123492.md) |
| Diluted EPS | $ per share | [7.92](/filings/0000950170-24-036902.md) | [5.66](/filings/0000950170-25-044864.md) | [(1.50)](/filings/0001193125-26-123492.md) | [(1.74)](/filings/0001193125-26-123492.md) | [1.25](/filings/0001193125-26-123492.md) |
| Free cash flow | $m | [186](/filings/0000950170-24-036902.md) | [(225)](/filings/0000950170-25-044864.md) | [34.5](/filings/0001193125-26-123492.md) | [46.8](/filings/0001193125-26-123492.md) | [83.7](/filings/0001193125-26-123492.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/gco/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [PZENA INVESTMENT MANAGEMENT LLC](/funds/1027796.md) | 2026-06-30 | $37.1m | 1,098,722 |  | Added +18,140 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $30.7m | 909,991 |  | Added +59,758 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $22.2m | 658,734 |  | Added +22,422 |
| [Fund 1 Investments, LLC](/funds/1959730.md) | 2026-06-30 | $20.6m | 609,963 |  | Added +184,653 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $13.7m | 404,847 |  | Reduced −58,576 |
| [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $12.5m | 369,700 | Put | Added +63,600 |
| [HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND](/funds/1535845.md) | 2026-06-30 | $10.1m | 300,000 |  | Unchanged |
| [CHARLES SCHWAB INVESTMENT MANAGEMENT INC](/funds/884546.md) | 2026-06-30 | $10.1m | 299,520 |  | Reduced −94,394 |
| [JACOBS LEVY EQUITY MANAGEMENT, INC](/funds/884414.md) | 2026-06-30 | $9.6m | 282,840 |  | Added +66,702 |
| [D. E. Shaw & Co., Inc.](/funds/1009207.md) | 2026-06-30 | $8.6m | 255,006 |  | Reduced −30,120 |

## Recent filings

[All 1,354 filings](/companies/gco/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-10 | 12:17 ET | [10-Q](/filings/0001193125-26-387556.md) | Quarterly report, period 2026-08-01 | 0001193125-26-387556 |
| 2026-09-03 | 07:15 ET | [8-K](/filings/0001193125-26-381023.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-381023 |
| 2026-08-06 | 06:53 ET | [8-K](/filings/0001193125-26-336643.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-336643 |
| 2026-08-03 | 16:56 ET | [SCHEDULE 13D/A](/filings/0000921895-26-001927.md) | Ownership report, active investor, amended | 0000921895-26-001927 |
| 2026-07-22 | 16:52 ET | [8-K](/filings/0001193125-26-312503.md) | 5.07 Shareholder vote results | 0001193125-26-312503 |
| 2026-06-29 | 06:51 ET | [8-K](/filings/0001193125-26-286803.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-286803 |
| 2026-06-11 | 10:47 ET | [10-Q](/filings/0001193125-26-266889.md) | Quarterly report, period 2026-05-02 | 0001193125-26-266889 |
| 2026-06-10 | 13:28 ET | [SCHEDULE 13D/A](/filings/0000921895-26-001594.md) | Ownership report, active investor, amended | 0000921895-26-001594 |
| 2026-06-01 | 16:21 ET | [10-K/A](/filings/0001193125-26-251478.md) | Annual report, amended, period 2026-01-31 | 0001193125-26-251478 |
| 2026-05-29 | 07:07 ET | [8-K](/filings/0001193125-26-246280.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-246280 |

## Latest annual report

[Form 10-K for the fiscal year ended Jan 31, 2026](/filings/0001193125-26-123492.md), filed Mar 25, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 18498
- Tickers: GCO
- Exchange: NYSE
- SIC code: 5661 Retail-Shoe Stores
- State of incorporation: TN
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:17 ET. No prices; not investment advice.